ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,728,957 | +11.3% | 2,421,743 | -0.1% | 1.88% | -2.2% |
| Q2 2023 | $24,918,319 | +39.3% | 2,423,961 | +4.6% | 1.92% | +13.5% |
| Q1 2023 | $17,892,134 | +5.0% | 2,317,634 | 0.0% | 1.70% | -15.2% |
| Q4 2022 | $17,034,610 | +6.8% | 2,317,634 | +4.6% | 2.00% | -5.9% |
| Q3 2022 | $15,946,000 | +126.6% | 2,214,722 | +167.9% | 2.13% | +51.5% |
| Q2 2022 | $7,036,000 | +133.3% | 826,779 | +145.9% | 1.40% | +75.8% |
| Q1 2022 | $3,016,000 | – | 336,229 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
| Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
| Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
| Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
| EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
| DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
| Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
| Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |